139 related articles for article (PubMed ID: 15247467)
1. Putting tolerance to the test.
Couzin J
Science; 2004 Jul; 305(5681):194-6. PubMed ID: 15247467
[No Abstract] [Full Text] [Related]
2. Transplant trials prove value of ITN.
Hollon T
Nat Med; 2000 Sep; 6(9):950. PubMed ID: 10973299
[No Abstract] [Full Text] [Related]
3. NIAID to begin clinical transplant tolerance trials.
Novak K
Nat Med; 1999 May; 5(5):470-1. PubMed ID: 10229212
[No Abstract] [Full Text] [Related]
4. Immunology. Gently soothing a savage immune system.
Couzin J
Science; 2002 Apr; 296(5567):456-8. PubMed ID: 11964457
[No Abstract] [Full Text] [Related]
5. The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials.
Elster EA; Hale DA; Mannon RB; Cendales LC; Swanson SJ; Kirk AD
Transpl Immunol; 2004; 13(2):87-99. PubMed ID: 15380539
[TBL] [Abstract][Full Text] [Related]
6. [Immune tolerance and antilymphocyte sera].
Kaden J
Z Arztl Fortbild (Jena); 1971 May; 65(9-10):522-8. PubMed ID: 5000438
[No Abstract] [Full Text] [Related]
7. NIAID spearheads collaborative network for clinical research on immune tolerance.
Klonoff DC
Diabetes Technol Ther; 2000; 2(1):124-5. PubMed ID: 11467312
[No Abstract] [Full Text] [Related]
8. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials. Diabetes' brave new world.
Couzin J
Science; 2003 Jun; 300(5627):1862-5. PubMed ID: 12817117
[No Abstract] [Full Text] [Related]
11. Diabetes. Islet transplants face test of time.
Couzin J
Science; 2004 Oct; 306(5693):34-7. PubMed ID: 15459359
[No Abstract] [Full Text] [Related]
12. [Autoimmune diseases and immunosuppressive therapy].
Pinther A
Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):177-81. PubMed ID: 4913085
[No Abstract] [Full Text] [Related]
13. The immune tolerance network: the "Holy Grail" comes to the clinic.
Bluestone JA; Matthews JB; Krensky AM
J Am Soc Nephrol; 2000 Nov; 11(11):2141-2146. PubMed ID: 11053493
[No Abstract] [Full Text] [Related]
14. Treating autoimmune diseases through restoration of antigen-specific immune tolerance.
Wolfraim LA
Arch Immunol Ther Exp (Warsz); 2006; 54(1):1-13. PubMed ID: 16642252
[TBL] [Abstract][Full Text] [Related]
15. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
Floersheim GL
Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
[No Abstract] [Full Text] [Related]
16. Promises and obstacles for the blockade of CD40-CD40L interactions in allotransplantation.
Li XL; Ménoret S; Le Mauff B; Angin M; Anegon I
Transplantation; 2008 Jul; 86(1):10-5. PubMed ID: 18622269
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery. Magnificent obsession.
Couzin J
Science; 2005 Mar; 307(5716):1712-5. PubMed ID: 15774740
[No Abstract] [Full Text] [Related]
18. Organ transplants. New drug blocks rejection in monkeys.
Vogel G
Science; 1999 Jun; 284(5420):1594-5. PubMed ID: 10383328
[No Abstract] [Full Text] [Related]
19. Standardization, more funds on horizon for clinical trials.
McNeil C
J Natl Cancer Inst; 2005 Apr; 97(8):555-7. PubMed ID: 15840874
[No Abstract] [Full Text] [Related]
20. [Problems and prospects of immunosuppressive treatment].
Bratkowska-Seniów B
Pol Tyg Lek; 1969 May; 24(20):745-6. PubMed ID: 5804320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
